These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment]. Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184 [No Abstract] [Full Text] [Related]
28. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine]. Clerc D; Sallière D; Segond P; Bisson M; Massias P Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465 [TBL] [Abstract][Full Text] [Related]
29. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis]. Camus JP; Crouzet J; Prier A; Leca AP Therapie; 1976; 31(3):385-97. PubMed ID: 136767 [No Abstract] [Full Text] [Related]
30. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis]. Tausch G; Bröll H; Eberl R Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434 [No Abstract] [Full Text] [Related]
31. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up]. Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516 [TBL] [Abstract][Full Text] [Related]
32. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis]. Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698 [TBL] [Abstract][Full Text] [Related]
33. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine. Redda A; Anastassiades T Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836 [TBL] [Abstract][Full Text] [Related]
34. Penicillamine for treatment of rheumatoid arthritis. Gordon MH; Ehrlich GE JAMA; 1974 Sep; 229(10):1342-3. PubMed ID: 4604882 [No Abstract] [Full Text] [Related]
35. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis. Dominkus M; Grisold W; Albrecht G Muscle Nerve; 1992 Nov; 15(11):1300-1. PubMed ID: 1488070 [No Abstract] [Full Text] [Related]
36. [Proteinuria in immunopathological diseases during long-term penicillamine therapy (author's transl)]. Hrncír Z; Tichý M Cas Lek Cesk; 1976 May; 115(18):549-51. PubMed ID: 1277236 [No Abstract] [Full Text] [Related]
38. [Severe side-effects of treatment with D-penicillamine (author's transl)]. Hennemann HH; Hubertus H; Stocker WG Dtsch Med Wochenschr; 1975 Aug; 100(32):1634-8. PubMed ID: 1172464 [TBL] [Abstract][Full Text] [Related]
39. [Behavior of the rheumatoid factor under long-term penicillamine therapy in primary chronic polyarthritis and lupus erythematosus disseminatus]. Prohaska E Wien Z Inn Med; 1966 May; 47(5):196-202. PubMed ID: 6005164 [No Abstract] [Full Text] [Related]
40. [D-penicillamine in rheumatoid arthritis : hematological incidents and accidents (author's transl)]. Franck JL; Bouteiller G; Gayrard M; Arlet J Sem Hop; 1979 Sep 8-15; 55(27-30):1325-7. PubMed ID: 228408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]